Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Treon

Showing results (51-60 of 323) with videos related to

Pageof 33
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|May 14, 2013
Challenges with serum protein electrophoresis in assessing progression and clinical response in patients with Waldenström macroglobulinemiaSacha N Uljon, Steven P Treon, Christina K Tripsas, et al.
Clinical Lymphoma & Myeloma|April 14, 2009
Ophthalmologic techniques to assess the severity of hyperviscosity syndrome and the effect of plasmapheresis in patients with Waldenström's macroglobulinemiaMarcel N Menke, Gilbert T Feke, J Wallace McMeel, et al.
Expert Review of Anticancer Therapy|April 11, 2022
Zanubrutinib for the treatment of adults with Waldenstrom macroglobulinemiaShayna Sarosiek, David Sermer, Andrew R Branagan, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 27, 2022
SOHO State of the Art Updates and Next Questions: Targeted therapies and emerging novel treatment approaches for Waldenström MacroglobulinemiaDavid Sermer, Shayna Sarosiek, Andrew R Branagan, et al.
British Journal of Haematology|July 6, 2017
Comparative outcomes of immunochemotherapy regimens in Waldenström macroglobulinaemiaAdam J Olszewski, Chang Chen, Roee Gutman, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
Report from the Sixth International Workshop on Waldenström's MacroglobulinemiaSteven P Treon, Giampaolo Merlini, Enrica Morra, et al.
Blood|March 6, 2002
Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cellsNicholas Mitsiades, Constantine S Mitsiades, Vassiliki Poulaki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2019
Reply to F.D. LeonardMark Bustoros, Romanos Sklavenitis-Pistofidis, Jorge J Castillo, et al.
Blood|February 21, 2014
Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemiaSteven P Treon, Yang Cao, Lian Xu, et al.
Leukemia & Lymphoma|January 22, 2026
Clinicopathological features and management of IgM multiple myeloma and Waldenstrom macroglobulinemiaShayna Sarosiek, Jorge J Castillo, Zachary R Hunter, et al.
Pageof 33

Showing results (51-60 of 323) with videos related to

Sort By:
Pageof 33
Clinical Lymphoma, Myeloma & Leukemia|May 14, 2013
Challenges with serum protein electrophoresis in assessing progression and clinical response in patients with Waldenström macroglobulinemiaSacha N Uljon, Steven P Treon, Christina K Tripsas, et al.
Clinical Lymphoma & Myeloma|April 14, 2009
Ophthalmologic techniques to assess the severity of hyperviscosity syndrome and the effect of plasmapheresis in patients with Waldenström's macroglobulinemiaMarcel N Menke, Gilbert T Feke, J Wallace McMeel, et al.
Expert Review of Anticancer Therapy|April 11, 2022
Zanubrutinib for the treatment of adults with Waldenstrom macroglobulinemiaShayna Sarosiek, David Sermer, Andrew R Branagan, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 27, 2022
SOHO State of the Art Updates and Next Questions: Targeted therapies and emerging novel treatment approaches for Waldenström MacroglobulinemiaDavid Sermer, Shayna Sarosiek, Andrew R Branagan, et al.
British Journal of Haematology|July 6, 2017
Comparative outcomes of immunochemotherapy regimens in Waldenström macroglobulinaemiaAdam J Olszewski, Chang Chen, Roee Gutman, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
Report from the Sixth International Workshop on Waldenström's MacroglobulinemiaSteven P Treon, Giampaolo Merlini, Enrica Morra, et al.
Blood|March 6, 2002
Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cellsNicholas Mitsiades, Constantine S Mitsiades, Vassiliki Poulaki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2019
Reply to F.D. LeonardMark Bustoros, Romanos Sklavenitis-Pistofidis, Jorge J Castillo, et al.
Blood|February 21, 2014
Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemiaSteven P Treon, Yang Cao, Lian Xu, et al.
Leukemia & Lymphoma|January 22, 2026
Clinicopathological features and management of IgM multiple myeloma and Waldenstrom macroglobulinemiaShayna Sarosiek, Jorge J Castillo, Zachary R Hunter, et al.
Pageof 33